Acetyl-L-carnitine (ALCAR)

Acetylated carnitine studied in Alzheimer's disease (Cochrane review found no benefit for cognition or function) and, in one open-label study, for mental fatigue in chronic fatigue syndrome.

Evidence
Preliminary evidenceGRADE certainty: Very low
Typical dose
Diabetic-neuropathy trials: 1,000 mg twice daily
Time to effect
Not established
Safety
Has documented cautions

Evidence ratings summarise published research on Acetyl-L-carnitine (ALCAR) in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.

Ask about Acetyl-L-carnitine (ALCAR)

Interactions

Taking any medication?

Check Acetyl-L-carnitine (ALCAR) against it.

Why

Acetyl-L-carnitine (ALCAR) is the acetylated form of L-carnitine, better blood-brain-barrier penetration than carnitine itself. A Cochrane review of 11 placebo-controlled trials in Alzheimer's disease found an early global-impression benefit at 12 and 24 weeks that was gone by 52 weeks, and no evidence of benefit on cognition, dementia severity or function. An open-label randomised study in 90 people with chronic fatigue syndrome (Vermeulen) reported less mental fatigue, but it had no placebo group.

How it works

Provides the acetyl group for acetylcholine synthesis, supports mitochondrial fatty-acid transport (the classical carnitine role), and crosses the blood-brain barrier where it modulates monoaminergic transmission and NGF activity in animal models.

Expected onset · Not established; the Alzheimer's trials assessed 12 to 52 weeks

How to take

Dosage

Diabetic-neuropathy trials: 1,000 mg twice daily. No dose is established for cognition, where trials found no lasting benefit.

Timing

Divided 2–3 times daily, away from large protein meals

On the label

'Acetyl-L-carnitine HCl' (or ALCAR) with stated mg per dose. Distinguished from plain L-carnitine and from L-carnitine tartrate (used more for athletic recovery).

Studied in

Adults with chronic fatigue exploring an option that has only exploratory evidence, under clinical guidance.

Safety

Possible activation, restlessness, insomnia at higher doses. Avoid late dosing. Theoretical risk of seizure-threshold lowering in epilepsy. Caution with thyroid hormones (may reduce thyroid hormone action). Pregnancy: limited data; coordinate with the prescribing clinician.
Loading interactions…

Evidence

At a glance

Hudson & Tabet 2003 Cochrane review (11 RCTs, Alzheimer's disease): more participants improved on clinical global impression at 12 and 24 weeks but not at 52 weeks, with no evidence of benefit for cognition, dementia severity or function. An open-label randomised study in 90 people with chronic fatigue syndrome (Vermeulen 2004) reported less mental fatigue with acetylcarnitine, without a placebo group.

GRADE certainty: Very low — rated by Healicus using the GRADE method

Questions people ask

Does Acetyl-L-carnitine (ALCAR) work?

Hudson & Tabet 2003 Cochrane review (11 RCTs, Alzheimer's disease): more participants improved on clinical global impression at 12 and 24 weeks but not at 52 weeks, with no evidence of benefit for cognition, dementia severity or function. An open-label randomised study in 90 people with chronic fatigue syndrome (Vermeulen 2004) reported less mental fatigue with acetylcarnitine, without a placebo group. Certainty of the evidence: Very low, rated by Healicus using the GRADE method.

How is Acetyl-L-carnitine (ALCAR) taken?

Diabetic-neuropathy trials: 1,000 mg twice daily. No dose is established for cognition, where trials found no lasting benefit. Timing: Divided 2–3 times daily, away from large protein meals. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.

Are there interactions or cautions?

Possible activation, restlessness, insomnia at higher doses. Avoid late dosing. Theoretical risk of seizure-threshold lowering in epilepsy. Caution with thyroid hormones (may reduce thyroid hormone action). Pregnancy: limited data; coordinate with the prescribing clinician. Documented drug and supplement interactions can be looked up in the free interaction reference.

What is the evidence based on?

Sources: Li et al., Cochrane Database Syst Rev 2015, acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy; Vermeulen & Scholte, Psychosom Med 2004, exploratory open label, randomised study of ALCAR and propionyl-L-carnitine in chronic fatigue syndrome; Hudson & Tabet, Cochrane Database Syst Rev 2003, acetyl-L-carnitine for dementia.

One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.